Lenalidomide-induced cytopenias: Relationship to hematologic improvement in patients with myelodysplastic syndromes (MDS)

被引：2
|
作者：
Sekeres, Mikkael A. [1 ]
Maciejewski, Jwoslaw P. [1 ]
Giagounidis, Aristoteles [2 ]
Wride, Kenton [3 ]
Knight, Robert D. [3 ]
Raza, Azra [4 ]
List, Alan F. [5 ]
机构：
[1] Cleveland Clin Taussig Canc, Cleveland, OH USA
[2] St Johannes Hosp, Duisburg, Germany
[3] Celgene Corp, Summit, NJ USA
[4] Univ Massachusetts, Med Ctr, Worcester, MA 01003 USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.821.821
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
821
引用
收藏
页码：252A / 252A
页数：1
相关论文
共 50 条
  • [41] Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)
    Al-Issa, Karam
    Madanat, Yazan F.
    Mukherjee, Sudipto
    Hirsch, Cassandra M.
    Gerds, Aaron T.
    Abuhadra, Nour
    Makhoul, Ahed
    Awada, Hassan
    Asad, Mohammad Fahad B.
    Goyal, Abhinav
    Advani, Anjali S.
    Kuzmanovic, Teodora
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Nazha, Aziz
    BLOOD, 2017, 130
  • [42] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Attar, Eyal C.
    Amrein, Philip C.
    Fraser, James W.
    Fathi, Amir T.
    McAfee, Steven
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Stone, Richard M.
    Foster, Julia
    Neuberg, Donna
    Ballen, Karen K.
    LEUKEMIA RESEARCH, 2013, 37 (09) : 1016 - 1020
  • [43] Combination of thalidomide and Enbrel for the treatment of patients with myelodysplastic syndromes (MDS).
    Raza, A
    Dutt, D
    Lisak, L
    Dean, L
    Fantroy, L
    Gezer, S
    Syed, E
    Goldberg, C
    Loew, J
    Hsu, WT
    Venugopal, P
    BLOOD, 2001, 98 (11) : 273B - 274B
  • [44] Preliminary results from a phase I study of Revlimid® (Lenalidomide) in combination with Vidaza® (Azacitidine) in patients with advanced myelodysplastic syndromes (MDS)
    Sekeres, Mikkael A.
    List, Alan
    Cuthbertson, David
    Paquette, Ronald
    Loughran, Thomas
    Maciejewski, Jaroslaw P.
    BLOOD, 2007, 110 (11) : 437A - 437A
  • [45] THE EFFECT OF LENALIDOMIDE ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: RESULTS FROM THE MDS-005 TRIAL
    Santini, V.
    Almeida, A.
    Giagounidis, A.
    Bartiromo, C.
    Hoenekopp, A.
    Guo, S.
    Beach, C.
    Altincatal, A.
    Wu, C.
    Skikne, B.
    Zhong, J.
    Hu, H.
    Fenaux, P.
    HAEMATOLOGICA, 2015, 100 : 68 - 68
  • [46] Final Results from a Phase I Combination Study of Lenalidomide and Azacitidine in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
    Sekeres, Mikkael A.
    List, Alan F.
    Cuthbertson, David
    Paquette, Ronald
    Latham, Deborah
    Afable, Manual
    Paulic, Katarina
    Loughran, Thomas P., Jr.
    Maciejewski, Jaroslaw P.
    BLOOD, 2008, 112 (11) : 88 - 89
  • [47] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Amrein, Philip C.
    Attar, Eyal C.
    Fathi, Amir Tahmasb
    McAfee, Steven L.
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Foster, Julia
    Stone, Richard M.
    Neuberg, Donna S.
    Ballen, Karen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] STUDY OF FREQUENCY AND PREDICTION IMPORTANCE OF THE CYTOPENIAS OF ISOLATED PRESENTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Milagros Aurora, Suito Alcantara
    Gomez Virginia, Escamilla
    Silvia del Rocio, Verdesoto Cozzarelli
    Maria Luz, Martino Galiana
    Jose Antonio, Perez Simon
    Jose Francisco, Falantes Gonzalez
    HAEMATOLOGICA, 2016, 101 : 64 - 65
  • [49] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) - update of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Sauer, A.
    Buschmann, D.
    Germing, U.
    Severin, K.
    Steinmetz, H. T.
    ONKOLOGIE, 2013, 36 : 242 - 242
  • [50] THE IMPACT OF MYELODYSPLASTIC SYNDROMES (MDS) ON THE MENTAL HEALTH OF PATIENTS AND CAREGIVERS
    Scheurmeyer, Isabel
    Hughes, Mary
    Sloan, Erika
    LeBlanc, Thomas
    Houk, Alice
    Sirewu, Nyaradzo
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
12345